Actualités Diagnos Inc - ADK | Actions TSX Venture Exchange

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

DIAGNOS Announces Closing of Private Placement

BROSSARD, Quebec, Feb. 05, 2025 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces Financial Contribution of $400,000 from the Government of Canada

BROSSARD, Quebec, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS to Present at The Microcap Conference 2025

BROSSARD, Quebec, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces the Engagement of Promoter

BROSSARD, Quebec, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock Exchange

BROSSARD, Quebec, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces Closing of Private Placement

BROSSARD, Quebec, Oct. 25, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces the Engagement of Market Maker Consultant

BROSSARD, Quebec, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces Grant of Stock Options

BROSSARD, Quebec, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX...

DIAGNOS Announces Voting Results of Meeting of Shareholders

BROSSARD, Quebec, Sept. 26, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces Variation in One Insider Ownership

BROSSARD, Quebec, Sept. 23, 2024 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Diagnos Inc...

DIAGNOS Announces Closing of Private Placement

BROSSARD, Quebec, Sept. 20, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders

BROSSARD, Quebec, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health Canada

BROSSARD, Quebec, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces Closing of Second and Final Tranche of Private Placement

BROSSARD, Quebec, June 05, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS celebrates the launch of Labtician’s new screening service for diabetic retinopathy in Ontario and renews its distribution agreement

BROSSARD, Quebec, May 21, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Diagnos Inc (ADK)

Outils de qualité professionnelle, pour des investisseurs individuels.

ADK Actualités

DIAGNOS Announces Closing of Private Placement

DIAGNOS Announces Financial Contribution of $400,000 from the Government of Canada

DIAGNOS to Present at The Microcap Conference 2025

DIAGNOS Announces the Engagement of Promoter

DIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock Exchange

DIAGNOS Announces Closing of Private Placement

DIAGNOS Announces the Engagement of Market Maker Consultant

DIAGNOS Announces Grant of Stock Options

DIAGNOS Announces Voting Results of Meeting of Shareholders

DIAGNOS Announces Variation in One Insider Ownership

DIAGNOS Announces Closing of Private Placement

DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders

DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health Canada

DIAGNOS Announces Closing of Second and Final Tranche of Private Placement

DIAGNOS celebrates the launch of Labtician’s new screening service for diabetic retinopathy in Ontario and renews its distribution agreement

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Diagnos Inc (ADK) Actualités

Diagnos Inc (ADK)

Outils de qualité professionnelle, pour des investisseurs individuels.

ADK Actualités

DIAGNOS Announces Closing of Private Placement

DIAGNOS Announces Financial Contribution of $400,000 from the Government of Canada

DIAGNOS to Present at The Microcap Conference 2025

DIAGNOS Announces the Engagement of Promoter

DIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock Exchange

DIAGNOS Announces Closing of Private Placement

DIAGNOS Announces the Engagement of Market Maker Consultant

DIAGNOS Announces Grant of Stock Options

DIAGNOS Announces Voting Results of Meeting of Shareholders

DIAGNOS Announces Variation in One Insider Ownership

DIAGNOS Announces Closing of Private Placement

DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders

DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health Canada

DIAGNOS Announces Closing of Second and Final Tranche of Private Placement

DIAGNOS celebrates the launch of Labtician’s new screening service for diabetic retinopathy in Ontario and renews its distribution agreement

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités